Biogen Idec Inc


  • Biogen Idec Draws "Line In The Sand" With Carl Icahn Wednesday, 6 Feb 2008 | 11:28 AM ET

    I'm blogging a little later than usual because I got sidetracked by the breaking news on the government stopping part of a big diabetes drug study over safety concerns--more people died in a group that was being intensively treated to get their blood sugar levels below current recommendations.

  • Biogen Profit Up on MS Drugs, Beats Estimates Wednesday, 6 Feb 2008 | 7:41 AM ET

    Biogen Idec said on Wednesday its fourth-quarter profit rose, driven by increased sales of its multiple sclerosis drugs Avonex and Tysabri.

  • Drug Stocks: Real Downers And At A Two-Year Low Tuesday, 5 Feb 2008 | 4:29 PM ET

    Yes, it was a big down day for equities, but I wanted to call attention to the fact that according to one of our resident stock gurus, Robert Hum, the Amex Pharmaceutical Index (you can see the 15 stocks that make up the so-called DRG here) closed at a two-year low today.

  • Exclusive: Icahn On Motorola & More Saturday, 2 Feb 2008 | 5:05 PM ET

    Legendary investor Carl Icahn details his battle to break up Motorola. Should you trade alongside this Wall Street dynamo?

  • Your First Move For Monday Feb 4th Friday, 1 Feb 2008 | 7:36 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Best Week In 5 Years Friday, 1 Feb 2008 | 6:23 PM ET

    Despite concerns about a weaker-than-expected jobs report, investors bid stocks higher, led by financial issues. Here's the word on the Street.

  • The Latest Picks That Paid – Friday Jan. 18th Friday, 18 Jan 2008 | 7:22 PM ET
    Quicker Ticker

    Our traders are good - but you knew that! Check out their latest picks that paid.

  • 4 Picks For Friday Thursday, 17 Jan 2008 | 7:25 PM ET

    In Thursday’s Web Extra we bring you stock picks that you'd typically find in the Final Trade. If you watched the TV show you know there wasn’t enough time to get to individual picks on air – but you will find them here!

  • Stocks Plunge 2% On Citi Earnings Tuesday, 15 Jan 2008 | 7:03 PM ET

    Stocks fell sharply on a growing conviction that the U.S. is headed toward recession. We’ve got the word on the Street including thoughts from Carl Icahn and Gov. Eliot Spitzer.

  • Drug from Biogen Idec, Elan Gets FDA Approval Monday, 14 Jan 2008 | 3:52 PM ET

    Biogen Idec and Elan Corp. have won U.S. approval to market the drug Tysabri for treating the bowel disorder Crohn's disease, U.S. regulators said on Monday.

  • DNA's Test Thursday, 10 Jan 2008 | 7:21 PM ET

    Genentech kicks off biotech earnings season Monday after the bell. Will higher sales of Avastin and Herceptin drive shares?

  • Lightning Round: Biogen, E*TRADE, Citigroup and More Tuesday, 8 Jan 2008 | 7:27 PM ET

    Cramer makes the call on viewers' favorite stocks.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Genzyme And Isis Steal Show With Cholesterol Drug Tuesday, 8 Jan 2008 | 10:28 AM ET

    After the closing bell Monday, Genzyme and Isis Pharmaceuticals announced a blockbuster deal that set the overcrowded halls abuzz here at the JPMorgan Healthcare Conference. They're partnering on an Isis drug in late-stage development for cholesterol. It's a once-a-week injectable for people who don't get their cholesterol low enough taking a statin like Lipitor, Crestor or Zocor.

  • Earnings Season Kicks Off Monday, 7 Jan 2008 | 7:13 PM ET

    Alcoa (AA) kicks off earnings season Wednesday after the bell. Which stocks and sectors look the best?

  • Okay, the real "Granddaddy of 'em all" was actually this past Tuesday at the Rose Bowl (I promise that's my last reference to the amazing USC Trojans unless they win a split national championship), but the granddaddy of healthcare investment conferences begins on Monday in San Francisco.

  • Healthy Returns? Friday, 4 Jan 2008 | 6:51 PM ET

    What's the trade heading into next week's JPMorgan Healthcare Conference?

  • My 7 For '07: The Pharma Year in Review Friday, 28 Dec 2007 | 1:57 PM ET

    The seven biggest stories in my sectors in 2007? Avandia, Dendreon, Pfizer, Biogen were just a few of the topics that made this a fascinating year for the pharmaceuticals and biotechnology industries.

  • Your First Move For Monday Dec. 17th Friday, 14 Dec 2007 | 7:22 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • The Fast Money Misfires Friday, 14 Dec 2007 | 6:55 PM ET

    Sometimes a stock is hot and other time it just burns. Following are the Fast Money misfires.

  • Novartis Cuts, While Biogen Idec Cuts And Runs Thursday, 13 Dec 2007 | 4:06 PM ET

    Novartis is the latest company to brand its downsizing, cost-cutting campaign. The Swiss drugmaker is calling its initiative, "Forward". It's not an acronym. So, "Forward" means Novartis is going to try to save $1.6 billion in 2010 and get rid of 2,500 employees. Although I don't think "Forward" is the word which begins with "f" that the affected workers would use to describe the initiative.